Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

BIO CEO & Investor Conference

13-Jan-2016
Finance | Pharmaceutical

8 - 9 February 2016, Conference, The Waldorf Astoria New York, NY, US

8 - 9 February 2016

Conference

The Waldorf Astoria New York, NY, US


Now in its 18th year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies.

Organiser: BIO (Biotechnology Innovation Organization)

www.bio.org

Related Content

Scarlet Therapeutics raises seed funding for rare disease treatment therapies
Scarlet Therapeutics raises seed funding for rare disease treatment therapies
Piramal reveals financial results for fourth quarter
Piramal reveals financial results for fourth quarter
Waters acquires "light scattering leader" Wyatt Technology
Waters acquires "light scattering leader" Wyatt Technology
SeraNovo and AstraZeneca to collaborate on research projects
SeraNovo and AstraZeneca to collaborate on research projects
WACKER purchases Spanish biotechnology company
WACKER purchases Spanish biotechnology company
Ascend launches as facilitator for gene therapy companies
Ascend launches as facilitator for gene therapy companies
AscellaHealth’s pharmaceutical financial solution for expensive specialty therapies
AscellaHealth’s pharmaceutical financial solution for expensive specialty therapies
DiNAQOR agrees acquisition to commercialise CGT development and manufacturing platform
DiNAQOR agrees acquisition to commercialise CGT development and manufacturing platform
Cytiva completes integration with Pall Corporation
Cytiva completes integration with Pall Corporation
Sanofi acquires Provention Bio and gains diabetes therapy
Sanofi acquires Provention Bio and gains diabetes therapy
Plasmid and lentiviral vector CDMO VectorBuilder orders rise by 70%
Plasmid and lentiviral vector CDMO VectorBuilder orders rise by 70%
PharmaLex reveals intention to merge with Cpharm
PharmaLex reveals intention to merge with Cpharm
Meridian set for $100m sterile fill-finish expansion in US
Meridian set for $100m sterile fill-finish expansion in US
Sartorious to acquire plasmid manufacturer Polyplus
Sartorious to acquire plasmid manufacturer Polyplus
Concept Life Sciences acquired by Limerston
Concept Life Sciences acquired by Limerston

This website stores data such as cookies to enable site functionality including analytics and personalization. By using this website, you automatically accept that we use cookies.

  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company